Trademark: SIENNA CANCER DIAGNOSTICS 1824912
Word
SIENNA CANCER DIAGNOSTICS
Device Descrption:
2 CIRCLES,ECCENTRIC DIVIDED BY STRIPES
ID
1824912
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
09 February 2017
Registration Date
09 February 2017
Renewal Date
09 February 2027
Owner(s)
Service
FB Rice Pty Ltd
Goods and Services:
Class 5:
Pharmaceutical, biotechnology and medical preparations and substances (for medical use or purposes); diagnostic preparations and reagents for medical purposes; antibodies; antibody fragments; antibody conjugates; preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for diagnostic use (medical); monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for use in the development of monoclonal antibodies (for medical purposes); molecular targets and associated information for drug and vaccine development, all in the nature of biological reagents; tagged antibodies for medical use; vaccines; vaccines against cancer viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, substances, products and testing materials for medical purposes; reagents for use in diagnostic tests (for medical purposes); reagents for medical research applications (for diagnosis); recombinant human protein production cell line; proteins for medical use in recombinant DNA technology; biological reagents for use in molecular biology
Pharmaceutical, biotechnology and medical preparations and substances (for medical use or purposes); diagnostic preparations and reagents for medical purposes; antibodies; antibody fragments; antibody conjugates; preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for diagnostic use (medical); monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for use in the development of monoclonal antibodies (for medical purposes); molecular targets and associated information for drug and vaccine development, all in the nature of biological reagents; tagged antibodies for medical use; vaccines; vaccines against cancer viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, substances, products and testing materials for medical purposes; reagents for use in diagnostic tests (for medical purposes); reagents for medical research applications (for diagnosis); recombinant human protein production cell line; proteins for medical use in recombinant DNA technology; biological reagents for use in molecular biology
Class 42:
Scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; drug discovery; vaccine screening, in the nature of (or for) research and development of vaccines; advisory services relating to diagnostic products; diagnostic testing services; medical research services; scientific research for medical purposes; pharmaceutical research services; diagnostic and research services and screening in the nature of research services in the field of diagnostic preparations; preparation of reports relating to medical, scientific and technical research; provision of information relating to medical, scientific and technical research; research and development of products; laboratory research; laboratory services (scientific research or analysis); analysis of tissues for medical research; antibody generation services being research and development services; molecular target discovery and development being services in this class
Scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; drug discovery; vaccine screening, in the nature of (or for) research and development of vaccines; advisory services relating to diagnostic products; diagnostic testing services; medical research services; scientific research for medical purposes; pharmaceutical research services; diagnostic and research services and screening in the nature of research services in the field of diagnostic preparations; preparation of reports relating to medical, scientific and technical research; provision of information relating to medical, scientific and technical research; research and development of products; laboratory research; laboratory services (scientific research or analysis); analysis of tissues for medical research; antibody generation services being research and development services; molecular target discovery and development being services in this class